Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Regions Financial Corporation Common Stock (RF) Price & Performance

Heron Therapeutics IncTrade
Regions Financial Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Regions Financial Corporation Common Stock — how do they compare? Heron Therapeutics Inc trades at $0.38 (market cap $68.01M), while Regions Financial Corporation Common Stock trades at $26.98 (market cap $23.06B). The key difference: Regions Financial Corporation Common Stock is far larger — about 339.1× Heron Therapeutics Inc's market cap, and Regions Financial Corporation Common Stock pays a 4.05% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Regions Financial Corporation Common Stock for 0 Days on average.

HRTXRF
Market Cap
$68.01M$23.06B
Volume
1,891,94113,190,101
Sector
HealthFinancials
52-Week High
$1.49$32.40
52-Week Low
$0.27$23.35
Typical Hold Time
35 Days0 Days
Enterprise Value
$174.75M$20.80B
Dividend Yield
—4.05%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.

The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.

Regions Financial Corporation Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
8% Buy92% Sell
Avg holding period · 35 Days
RF
100% Buy0% Sell
Avg holding period · 0 Days

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About Regions Financial Corporation Common Stock

Regions Financial is a financial holding company that operates through Regions Bank. It provides consumer, commercial, mortgage, wealth-management, and investment services across the South, Midwest, and Texas.

Read more on RF →